New pathways identified to reduce pain and depressive symptoms associated with fibromyalgia
Fibromyalgia is a chronic condition affecting between 2% and 6% of the global population, characterized by widespread, persistent pain often associated with fatigue, sleep disturbances, cognitive difficulties and affective symptoms. Despite its high prevalence—particularly among women—the mechanisms
<p>Fibromyalgia is a chronic condition affecting between 2% and 6% of the global population, characterized by widespread, persistent pain often associated with fatigue, sleep disturbances, cognitive difficulties and affective symptoms. Despite its high prevalence—particularly among women—the mechanisms</p>